Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-09, Stock:NVS, The news for the past five days is as follows:
2020-11-02: NEWS1: Novartis Expands Presence in Gene Therapy With Acquisition.NEWS2: Top Analyst Reports for PayPal, Comcast & Novartis.NEWS3: Analyst Report: Novartis AG.NEWS4: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, Pfizer, Novartis, AstraZeneca and J&J.NEWS5: Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention.
2020-11-03: NEWS1: The Zacks Analyst Blog Highlights: PayPal, Comcast, Novartis, BlackRock and FedEx.
2020-11-04: nan
2020-11-05: NEWS1: Incyte Earnings Miss Expectations; Tightens Outlook For Top Product.NEWS2: Incyte Earnings Miss Expectations; Tightens Outlook For Top Product.NEWS3: Incyte (INCY) Q3 Earnings & Sales Miss, Jakafi Demand Strong.NEWS4: Ionis (IONS) Misses Estimates for Q3 Earnings and Sales.NEWS5: Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study.
2020-11-06: NEWS1: The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold.NEWS2: Novartis arthritis drug fails to help COVID-19 patients.NEWS3: Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS).

Answer: Decrease